DCCC would like to ensure that we have your most current information. Please click below to update your information.
Annually, more than 4,400 patients participate in. . .

Duke Hosts International Conference Focused on New Treatment for Prostate and Kidney Cancers
Prostate and kidney cancer. . .

155 Miles in the Gobi Desert. . .To Fund Cancer Research
In December 2008, Andrew Swan received devastating news. His friend Nathan Strickland had been diagnosed with a brain tumor. . .
New Combination of Therapies Prolongs Life


Breast oncologist Kimberly Blackwell, MD, recently reported evidence that a combination-targeted therapy of lapatinib plus trastuzumab gave patients whose breast tumors are HER2-positive more than a four-month survival advantage over those patients who took lapatinib alone.
© Copyright 2010 - Duke Comprehensive Cancer Center - All rights reserved.